CytoSorbents Corporation Watch

from 10-Q 2 pages Signature Page Follows

from 8-K 5 pages This Agreement (The “Agreement”) Entered Into as of August 13, 2024 Between Kathleen P. Bloch (“Consultant”) and Cytosorbents Corporation and Its Wholly-Owned Subsidiary Cytosorbents Medical, Inc., Both Delaware Corporations, With Offices at 305 College Road East, Princeton, Nj 08540 (Collectively, the “Company”)

from 8-K 11 pages Nonstatutory Stock Option Notice Grant No

from 8-K 11 pages Cytosorbents Corporation Nonstatutory Stock Option Notice

from 8-K 8 pages Pursuant to the Terms of the Employment Agreement, Dated August 14, 2024 Between the Company and You (As It May Be Amended From Time to Time, the “Employment Agreement”), You Are to Be Granted Restricted Stock Units on the Terms and Subject to the Conditions Set Forth Herein. the Board of Directors of the Company Has Decided to Make This Restricted Stock Unit Grant as a Material Inducement for You to Enter Into Employment With the Company and to Align Your Interests With Those of the Company and Its Stockholders. the Grant of the Restricted Stock Units Provided for Herein Is Intended to Constitute an “Employment Inducement Grant” as Described in Rule 5635(c)(4), or Any Successor Provision, of the NASDAQ Listing Rules, and Is Not Being Granted or Made Under the Cytosorbents Corporation 2014 Long-Term Incentive Plan, as Amended From Time to Time (The “Plan”). 1. Terminology. Unless Otherwise Provided in This Agreement, Capitalized Terms Used Herein Are Defined in the Glossary at the End of This Agreement Or, in the Plan, as Applicable. 2. Grant

from 8-K 20 pages Executive Employment Agreement

from 8-K 14 pages Warrant to Purchase Shares of Stock of Cytosorbents Corporation

from 8-K 8 pages Cytosorbents Corporation Nonstatutory Stock Option Notice Grant No

from 8-K 2 pages March 29, 2024 [Name] [Address of Employee] Re: Salary Reduction Agreement

from 8-K 60 pages Information in This Exhibit Identified by [***] Is Confidential and Has Been Excluded Pursuant to Item 601(b)(10)(iv) of Regulation S-K. Securities Purchase Agreement

from 8-K 17 pages Information in This Exhibit Identified by [***] Is Confidential and Has Been Excluded Pursuant to Item 601(b)(10)(iv) of Regulation S-K. Executive Employment Agreement

from 10-Q 8 pages Material contract

from 8-K 18 pages Executive Employment Agreement

from 8-K 5 pages Certain Information Identified by [***] Has Been Excluded Pursuant to Item 601(b)(10)(iv) of Regulation S-K Because Such Information Is Not Material and Is Private or Confidential

from 10-K 7 pages Material contract

from 10-K 6 pages Material contract

from 10-Q 17 pages Marketing Agreement

from 8-K 4 pages Success Fee Letter Cytosorbents Corporation 7 Deer Park Drive Suite K Monmouth Junction, Nj 08852 January 19, 2022

from 8-K 70 pages Lease of Premises

from 10-Q 5 pages Nineteenth Amendment to Lease